Pulsenmore Ltd. Ordinary Shares (NASDAQ:PLSM) — Market Cap & Net Worth
Market Cap & Net Worth: Pulsenmore Ltd. Ordinary Shares (PLSM)
Pulsenmore Ltd. Ordinary Shares (NASDAQ:PLSM) has a market capitalization of $21.78 Million ($21.78 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #24768 globally and #5051 in its home market, demonstrating a -8.47% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pulsenmore Ltd. Ordinary Shares's stock price $3.35 by its total outstanding shares 6502844 (6.50 Million). Analyse Pulsenmore Ltd. Ordinary Shares (PLSM) cash conversion ratio to see how efficiently the company converts income to cash.
Pulsenmore Ltd. Ordinary Shares Market Cap History: 2026 to 2026
Pulsenmore Ltd. Ordinary Shares's market capitalization history from 2026 to 2026. Data shows growth from $21.78 Million to $21.78 Million (0.00% CAGR).
Pulsenmore Ltd. Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pulsenmore Ltd. Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of PLSM by Market Capitalization
Companies near Pulsenmore Ltd. Ordinary Shares in the global market cap rankings as of May 4, 2026.
Key companies related to Pulsenmore Ltd. Ordinary Shares by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Pulsenmore Ltd. Ordinary Shares Historical Marketcap From 2026 to 2026
Between 2026 and today, Pulsenmore Ltd. Ordinary Shares's market cap moved from $21.78 Million to $ 21.78 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $21.78 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Pulsenmore Ltd. Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $21.78 Million USD |
| MoneyControl | $21.78 Million USD |
| MarketWatch | $21.78 Million USD |
| marketcap.company | $21.78 Million USD |
| Reuters | $21.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Pulsenmore Ltd. Ordinary Shares
Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. The company offers Pulsenmore home ultrasound system, a handheld ultrasound cradle dock with the patient's smartphone; mobile app for uploading images to the cloud for review; and clinician dashboard for clinician to review a stored video or guide a scan in re… Read more